10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,601,832 | -26.1% | 38,823 | +0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,167,014 | -0.1% | 38,811 | -0.1% | 0.00% | 0.0% |
| Q1 2023 | $2,168,191 | +297.1% | 38,860 | +159.4% | 0.00% | – |
| Q4 2022 | $546,051 | +27.8% | 14,979 | -50.0% | 0.00% | – |
| Q3 2022 | $427,427 | -44.1% | 29,958 | +77.5% | 0.00% | -100.0% |
| Q2 2022 | $764,000 | -82.1% | 16,879 | -69.9% | 0.00% | -50.0% |
| Q1 2022 | $4,269,000 | -88.9% | 56,111 | -78.2% | 0.00% | -87.5% |
| Q4 2021 | $38,373,000 | +644.0% | 257,610 | +627.2% | 0.02% | +700.0% |
| Q3 2021 | $5,158,000 | +575.1% | 35,427 | +808.9% | 0.00% | – |
| Q2 2021 | $764,000 | -85.1% | 3,898 | -89.2% | 0.00% | -100.0% |
| Q4 2020 | $5,125,000 | +256.9% | 36,192 | +27.1% | 0.00% | +100.0% |
| Q3 2019 | $1,436,000 | – | 28,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 750,000 | $111,720,000 | 99.68% |
| Foresite Capital Management II, LLC | 1,753,528 | $261,206,000 | 99.34% |
| Venrock Management VI, LLC | 962,309 | $143,346,000 | 96.17% |
| 12 West Capital Management LP | 2,004,000 | $298,516,000 | 13.24% |
| FINANCIAL CONSULATE, INC | 154,942 | $23,080,000 | 8.00% |
| Meritech Capital Associates V L.L.C. | 1,610,824 | $239,948,000 | 7.68% |
| Andar Capital Management HK Ltd | 55,000 | $8,193,000 | 7.52% |
| JS Capital Management LLC | 540,589 | $80,526,000 | 3.66% |
| HARVARD MANAGEMENT CO INC | 186,143 | $27,728,000 | 2.60% |
| Connective Portfolio Management, LLC | 7,000 | $1,056,000 | 1.86% |